Hims' partner Strive reportedly planning to launch copies of Novo's Wegovy pill
2026-03-03 10:27:45 ET
More on Hims & Hers Health, Novo Nordisk A/S
- Pricing Pressure And Panic: What The Market May Be Missing In Novo Nordisk
- Hims & Hers Health, Inc. (HIMS) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript
- Eli Lilly Vs. Novo Nordisk: The Valuation Gap Is Unreasonable
- Novo’s China obesity drug posts positive mid-stage trial results
- Hims & Hers Health discloses SEC investigation over copycat GLP-1s; stock falls
Read the full article on Seeking Alpha
For further details see:
Hims’ partner Strive reportedly planning to launch copies of Novo’s Wegovy pillNASDAQ: NONOF
NONOF Trading
-0.75% G/L:
$38.46 Last:
16,693 Volume:
$38.50 Open:



